mpathic

🌟 Introducing mpathic's brand new monthly newsletter, launching this May! 🔹 What to Expect? You'll get a behind-the-scenes look at mpathic's latest projects, milestones, and the dedicated people driving our technology forward. It’s a streamlined way to get your monthly dose of mpathic insights and updates, straight to your inbox. ➡️ Join Us! Visit www.mpathic.ai and as you begin to navigate away from our website, a sign-up pop-up will appear. Sign up and become a part of the mpathic community.

The FDA's recent feedback on MDMA-assisted therapy for PTSD highlights the critical paths to achieving regulatory approval, spotlighting the necessity for standardization, oversight, reducing bias, patient safety, and treatment efficacy. Facing these challenges, it's clear we need innovative approaches in clinical trials. At mpathic, our mTrial technology shines as a promising solution, designed to boost trial adherence, improve quality oversight, and minimize bias. The journey to enhance psychedelic drug development and mental health treatment continues. With AI integration, we're taking a crucial step forward in refining research methodologies, aiming for more effective mental health treatments. This moment in healthcare is not just about overcoming obstacles; it's about transforming how we approach mental health treatment development. For more details, visit: https://lnkd.in/eUs8P3tX. I'm excited to share our commitment to advancing mental health care. #mpathic #HealthcareInnovation #MentalHealth #PsychedelicResearch #FDA #AIInHealthcare

The FDA's decision not to approve MDMA-assisted therapy for PTSD highlights the complex journey toward regulatory approval and the significant insights provided by the Psychopharmacologic Drugs Advisory Committee regarding areas such as standardization, oversight, bias, patient safety, and treatment efficacy. In light of these challenges, the moment has come to advocate for innovative quality oversight approaches to clinical trials. Technologies like mTrial present promising avenues that improve trial adherence, enhance quality oversight, and minimize bias. The advancement of psychedelic drug development research is far from over, and with the integration of AI, we're embarking on a crucial step toward developing more effective treatments for mental health. This marks a transformative step in refining research methodologies, setting us on a path to achieving more effective treatments for mental health. Discover more at https://lnkd.in/eUs8P3tX #ClinicalTrials #PsychedelicResearch #FDA #AI #Innovation #mTrial

An article in MobiHealthNews highlights nine areas where AI is advancing healthcare, including clinical trials. As a partner in the healthcare and life sciences sector, we're excited to showcase how our AI solution, mTrial, is transforming clinical trials. 🔍 Enhancing Patient and Client Engagement: Reducing drop-out rates and improving recruitment. 📊 Optimizing Decision-Making: Providing actionable insights for better trial management. ✅ Upholding Quality Assurance: Ensuring high performance standards across multi-site trials. 🛡️ Prioritizing Safety: Mitigating risks and ensuring patient well-being. 📈 Maintaining Fidelity: Achieving superior accuracy in trial monitoring. Discover how mTrial is setting new benchmarks in clinical trials and shaping the future of healthcare. https://lnkd.in/eTgg72T4 #ClinicalTrials #LifeSciences #mpathic #Fidelity

Seattle, here we come! 🚀 The mpathic team will be attending The American Psychological Association (APA) 2024 conference August 8-10, where Dr. Alison Cerezo, Dr. Amber Jolley-Paige, Ph.D., and Dr. Grin Lord are scheduled to lead two notable discussions. In our first talk, "Establishing Standard Benchmarks for the Use of AI in Mental Health Care," we will emphasize the importance of clear guidelines for integrating AI in clinical environments. Our second talk, "Leveraging AI to Deliver Culturally Responsive Mental Health Care at Scale," will discuss innovative methods of providing mental health services that are attuned to the diverse cultural backgrounds of individuals. Are you attending the conference and interested in meeting our team? 🔗 Schedule a meeting with us: https://buff.ly/3WLSo89 #APA2024 #AIinMentalHealth #Seattle

We had a fantastic time co-hosting the "Innovate & Unwind" mixer last night with Therapists in Tech during #SeattleTechWeek. A big thanks to everyone who joined us on The Collective's patio for engaging conversations and great company. A special shoutout to our co-hosts, Dr. Grin Lord and David Cooper, PsyD,  and to all the AI and mental health tech enthusiasts who attended, and to Madrona Venture Labs for sponsoring Seattle Tech Week. Your presence and participation made the evening a wonderful success! We’re looking forward to more events where we can come together to network and explore the future of tech and mental health! #mpathic #TherapistsInTech #SeattleTechWeek #TechNetworking

🌟 The Medical Memory™ app enhances patient care by offering innovative video education resources and recording doctor-patient interactions. This platform streamlines documentation and reduces task-switching interruptions, allowing providers to focus on what truly matters — patient care. 🚀 mpathic product, mConsult, seamlessly integrates with Medical Memory, enhancing doctor-patient communication. Through real-time detection and AI-driven insights, mConsult empowers healthcare professionals with generative suggestions that enable them to convey empathy in every interaction. 💡mpathic and Medical Memory’s partnership improves patient understanding, satisfaction, and ultimately, health outcomes. Learn more about how mConsult improves doctor-patient communication: https://buff.ly/3yaqCIR #HealthcareInnovation #AIInHealthcare #PatientCare #mpathic

Clinical Core Intern Wanted at mpathic! mpathic is hiring for a contract-based Clinical Core Intern to join our team, helping shape the future of AI in Life Sciences. What You'll Do: - Train to annotate and analyze conversations, identifying empathic interactions. - Label key elements within Life Sciences conversations. - Work remotely and flexibly, 10+ hours per week. Who You Are: - A self-starter with a background in counseling, psychology, or social work. - Equipped for remote work with good problem-solving skills. - Bonus points for experience with clinical coding or an interest in AI and machine learning. What's Offered: - $20/hr. during training, and up to $30/hr. post-training. - A highly adaptable work schedule. - Work from anywhere within the US (eligibility to work in the US required). - Please note, this contract role does not offer medical benefits. We're looking forward to welcoming a new team member! Please submit your resume, cover letter, and two references through the following link: https://lnkd.in/dMgJnbbh #Hiring #RemoteJob #ClinicalIntern #TechInnovation #mpathic

Don't forget to mark your calendars, in two weeks is the Innovate & Unwind Networking Mixer hosted by mpathic and Therapists in Tech! 📆 #SeattleTechWeek2024 #AI #MentalHealth #TechNetworking

mpathic is proud to announce it has received a grant from the National Institutes of Health Small Business Innovation Research (SBIR) program in collaboration with Wave , which will support our work in addressing racial bias in healthcare. With this effort, we aim to understand and significantly reduce the barriers that racial and ethnic minorities face when seeking mental health services. Leading our research is Dr. Alison Cerezo, mpathic's SVP of Research & Health Equity, whose work is grounded in the integration of clinical expertise and cultural insight. "There are ways that people are developing apps off the cuff, which can be dangerous and scary," Dr. Cerezo explains. "We recognize the barriers that prevent providers from delivering quality care. Therefore, this project is one of our strategies to integrate solutions into systems, ensuring that AI can benefit both providers and patients effectively." The transformative potential of generative AI in enhancing access to care is immense, provided it is developed with consideration and responsibility. In partnership with Wave, we are establishing enhanced conversation analytics that accurately capture the essence of culturally competent communication. The anonymized data provided by Wave plays a crucial role in refining our models to achieve these objectives. Echoing this commitment to innovation, Sarah Adler, PsyD from Wave emphasizes the necessity for advancements in generative AI to have clinical validity at their core, signaling the potential of such technology to fundamentally change mental health services. We appreciate Healthcare Innovation and journalist David Raths for featuring our joint initiative. https://lnkd.in/ecBDQqeM At mpathic, we are committed to pushing forward with our collaboration with Wave, facing the challenge head-on to ensure that generative AI serves as a beneficial tool in healthcare, paving the way for quality, empathy-driven care for all. #mpathic #HealthcareInnovation #MentalHealthEquity #GenerativeAI